AlphaYouJS
Insider selling
Jeffrey S. Heier sold $36K of Ocular Therapeutix, Inc (OCUL) stock
Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc (OCUL), sold 3,296 shares of OCUL stock worth $36K, per an SEC Form 4 filed Aug 26, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 24, 2026, 2 days before it was made public.
OCUL has moved -7.3% since the trade date, from $10.78 to $9.99 (Sep 21, 2026 close).
- Traded
- Aug 24, 2026
- Disclosed
- Aug 26, 2026
- Filing delay
- 2 days
- Price since
- -7.3%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More OCUL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.